Clinical Trial Supplies Market by Phase, Type, Product, Therapeutic Area, End User

List of Tables

[199 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

KEY MARKET STATISTICS
Base Year [2023]	USD 3.35 billion
Estimated Year [2024]	USD 3.64 billion
Forecast Year [2030]	USD 5.92 billion
CAGR (%)	8.43%

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Clinical Trial Supplies Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of infectious and chronic diseases worldwide
- Rising research and development expenditure by pharmaceutical and biopharmaceutical industry

Market Restraints
- High cost of clinical trial supplies

Market Opportunities
- Emphasis on drug development and shift towards patient-centric clinical trials
- Ongoing advancements in a diverse range of clinical trial supplies

Market Challenges
- Stringent regulations for clinical trial supplies

Market Segmentation Analysis
- Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
- Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
- Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
- Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
- End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supplies Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal

Permira, a UK private equity firm, agreed to acquire Ergomed for USD 888.1 million. Ergomed is a clinical trial development and management services provider, catering to clients across more than 100 countries. This strategic acquisition can expand Permira's already impressive portfolio of medical companies, including Neurapharm and Cambrex. [Published On: 2023-09-04]

Thermo Fisher Scientific Launches New Smart Refrigerator Series

Thermo Fisher Scientific introduced the Thermo Scientific TM TSG series refrigerators, specifically engineered to cater to the stringent demands of diverse industries. These cutting-edge refrigerators leverage advanced technology to ensure accurate temperature control, effectively preserving the integrity of vaccines and pharmaceuticals. By minimizing temperature fluctuations, these refrigerators effectively mitigate the risks associated with such variations, safeguarding medical products' potency and efficacy. [Published On: 2023-08-16]

Loftware and Tenthpin Collaborate on Clinical Supply Labeling

Loftware and Tenthpin collaborated to launch a software called Loftware Prisym 360, which is specifically designed for clinical supply labeling. The main objective of this partnership is to address the growing challenges faced by clinical trial supply teams within the pharmaceutical industry. This agreement enables both Loftware and Tenthpin to actively promote, educate, and implement a comprehensive content and labeling solution for their clinical customers. [Published On: 2023-08-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supplies Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Phase
- Phase I
- Phase II
- Phase III
- Phase IV

Type
- Biologic Drugs
- Medical Devices
- Small-Molecules

Product
- Auxiliary Medicinal Products
- Interactive Response Technology (IRT) solutions
- Lab Supplies
  - Centrifuges
  - Microscopes
  - Pipettes
  - Reagents

Medical Devices & Diagnostics
Pharmacy Supplies
- Biohazard Bags
- Compounding Aseptic Isolators
- Sterilization Equipment

Research Materials
Safety Equipment

Therapeutic Area
- Cardiology
- Genetic Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Neurology
- Oncology

End User
- Contract Research Organisations
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-E0619F076721

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
  - 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
- 5.1.2. Restraints
  - 5.1.2.1. High cost of clinical trial supplies
- 5.1.3. Opportunities
  - 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
  - 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations for clinical trial supplies
5.2. Market Segmentation Analysis
- 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
- 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
- 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
- 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
- 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
5.3. Market Trend Analysis
- 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
- 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
- 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Clinical Trial Supplies Market, by Phase

6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

8.1. Introduction
8.2. Auxiliary Medicinal Products
8.3. Interactive Response Technology (IRT) solutions
8.4. Lab Supplies
8.5. Medical Devices & Diagnostics
8.6. Pharmacy Supplies
8.7. Research Materials
8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

9.1. Introduction
9.2. Cardiology
9.3. Genetic Diseases
9.4. Immunology
9.5. Infectious Diseases
9.6. Metabolic Disorders
9.7. Neurology
9.8. Oncology

10. Clinical Trial Supplies Market, by End User

10.1. Introduction
10.2. Contract Research Organisations
10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
- 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
- 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
- 14.3.4. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
- 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
- 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
- 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
- 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
- 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
- 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
- 14.3.11. Experic Closes USD 14 Million Series B Financing
- 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio